In addition, low expression of GATA3 was associated with a poor survival rate and more aggressive disease, whereas GATA3-expressing breast cancer patients had a better prognosis, were less likely to relapse, and had a better overall survival rate [85]. The gene discussed is GATA3; the disease is breast cancer.